The dieline comes back from the printer with the logo in the right place and the required panel in the wrong one. For a DTC supplement founder, an OTC brand manager, or a device director who needs FDA compliant supplement label dielines, that is a launch delay, not a design note. Fix the five placement mistakes before you chase a prettier hierarchy. This is for the people who approve the file, not for a shopper choosing a product, and it is not a claim that any label is “FDA approved.”
Fix five placement mistakes before you restyle the front. Put the required panel where the rule for that product says it goes, give mandatory symbols the size and clear space the named standard requires, stop the marketing lockup from covering them, make the marketplace image show the same required panel as the physical unit, and leave a bleed and a fold that do not eat the type. A converting hierarchy only works after those five are true.
Shelf QA and a marketplace review do not grade taste. They look for the panel, the type size, and the symbol that has to be readable when the unit is on a peg or in a thumbnail. A file that wins in a deck and fails that check sits in a revision loop while the inventory date does not move.
The trap is treating three products as one label. A dietary supplement, an OTC drug, and a medical device do not share one panel. Supplement Facts, Drug Facts, and a device label that uses ISO 15223-1 symbols are different jobs. The dieline has to say which product this is before anyone moves a text box. If you are not sure, stop and ask the person who owns regulatory for that SKU. Do not borrow the neighboring brand’s panel because it “looked compliant.”
The principal display panel is the part of the package most likely to be seen at retail. It is not “wherever the logo looks best.” On a dietary supplement, FDA guidance places the statement of identity and the net quantity of contents on the principal display panel, and places the Supplement Facts panel, ingredient list, and business name on the information panel when they do not appear on the front. On an OTC drug, FDA requires a standardized Drug Facts format with a fixed heading order. On a device, symbols used to express manufacturer-supplied information must follow the symbol set the label claims to use, including ISO 15223-1 when that standard is in scope for the SKU.
If the visual hierarchy needs the brand large, give it the space that is left after the panel, the quantity, and the symbols have an address. Brands lose weeks by doing this backwards: locking the hero, then shrinking the required type until it fits. QA sends it back. The second round is the same conversation with less time.
Walk the dieline with this list before the file goes to print or to the marketplace. One miss is enough to restart the clock.
The five placement mistakes
- Wrong panel for the product. A supplement does not wear a Drug Facts box, an OTC drug does not wear a Supplement Facts box, and a device does not borrow either one to look “clinical.” FDA notes that Drug Facts requirements do not apply to dietary supplements, which use Supplement Facts instead.
- Symbols with no size or no spot. If the product needs ISO 15223-1 symbols, they need clear space and a readable size on the built unit, not a row of icons tucked under the logo. Confirm size and placement against the standard your regulatory owner named for that SKU.
- Marketing covering the required type. A claim, a badge, or a pattern that runs through the panel makes the required text fail even when the words are technically present.
- Marketplace frame that hides the panel. The main product image must match the physical panel a reviewer would see on the unit. Do not invent a digital panel that the carton does not carry.
- Fold, seam, or bleed eating the type. A dieline that looks correct flat can put a required line on a curve, a crimp, or the trim. Check the built carton, not only the flat art.
If any of the five is unmarked, pause the restyle and fix the placement first. A short recorded walkthrough of the flat and built dieline is often enough for a founder and a regulatory owner to see the miss before retail QA does. That label dieline video audit is packaging work, not a new brand theme.
High-converting hierarchy is not a second set of claims. It is the order a buyer’s eye takes once the required pieces are immovable. Brand, product name, and the one commercial difference you are allowed to say should be readable at arm’s length and in a thumbnail. Everything else steps back.
Do not add a disease claim, a dose instruction, or a “clinically proven” line to win the shelf. Those are not design choices. If a statement needs a substantiation file, it does not go on the dieline because the layout felt empty. Empty and accurate ships. Clever and indefensible comes back.
The same restraint belongs in marketplace detail modules. Those modules can show the pack, the routine, and how to find the product on a shelf. They should not invent a benefit the physical label is not allowed to carry. Reviewers compare the two. When the digital frame says more than the carton, you have created a second label you now have to defend.
Send a flat dieline and a simple built view, with the five checks marked. Name the product class in the file name so nobody applies the wrong panel. Note which symbols are in use and that their size was checked against the named standard, not against the logo. Attach the marketplace frame beside the physical panel so the two can be read together.
If a symbol or a panel still has an open question, write the question on the proof. Do not hide it inside a “we’ll fix it in prepress” note. Prepress is where required type gets nudged onto a seam.
Which of the five is still unmarked on the file you are about to send?
- FDA, Dietary Supplement Labeling Guide (landing page and related chapters for statement of identity, net quantity, and Supplement Facts placement). Checked on October 4, 2026.
- FDA, The Over-the-Counter Drug Facts Label (standardized Drug Facts format; note that Drug Facts requirements do not apply to dietary supplements). Checked on October 4, 2026.
- ISO, ISO 15223-1:2021 — Medical devices — Symbols to be used with information to be supplied by the manufacturer — Part 1: General requirements. Checked on October 4, 2026.
